C

Compass Pathways

Develops psilocybin-based therapies for TRD

Director – Omnichannel and Digital Strategy

Growth MarketingConfirmed live in the last 24 hours
Full-time

About the Job

Requirements

  • A bachelor's degree in Marketing, Business, Data Science, Computer Science, or a related field is required.
  • Eight to ten or more years of experience in omnichannel marketing, digital strategy, marketing technology, or commercial operations within the pharmaceutical or biotechnology industry is required.
  • Demonstrated experience designing and implementing omnichannel engagement strategies in pharmaceutical commercial organizations is required.
  • A strong understanding of pharmaceutical marketing regulations and compliance requirements, including FDA promotional guidelines and MLR review processes, is required.
  • Experience implementing or managing marketing automation, CRM platforms, and digital engagement ecosystems commonly used in pharmaceutical environments is required.
  • Hands-on experience building or deploying AI-enabled tools or software capabilities that support next best actions, predictive targeting, or marketing optimization is required.
  • A strong understanding of data-driven marketing, customer journey orchestration, and campaign analytics in healthcare or life sciences is required.
  • Excellent communication and stakeholder management skills and the ability to collaborate across marketing, sales, analytics, IT, and compliance teams are required.

Responsibilities

  • Develop and execute the company's omnichannel engagement strategy to support commercial launch and long-term brand growth within the pharmaceutical market.
  • Design and implement digital ecosystems that enable personalized engagement across email, web, CRM, field engagement tools, and marketing automation platforms.
  • Lead the development of next best action capabilities using AI and advanced analytics to optimize healthcare provider engagement and field effectiveness.
  • Oversee digital campaign strategy, including email marketing programs, triggered journeys, and audience segmentation aligned with pharmaceutical marketing standards.
  • Partner with Marketing and Medical teams to develop scalable digital content strategies and modular content frameworks that meet regulatory and compliance requirements.
  • Evaluate, implement, and manage digital platforms and software that support omnichannel engagement, marketing automation, and content management.
  • Collaborate with Commercial Analytics to integrate CRM data, behavioral data, and external healthcare datasets into engagement strategies.
  • Drive the adoption and optimization of AI-enabled tools that enhance personalization, predictive targeting, and campaign effectiveness.
  • Partner with IT and external vendors to build and deploy digital solutions while ensuring compliance with pharmaceutical regulatory, privacy, and data governance standards.
  • Develop measurement frameworks and dashboards to track omnichannel performance, campaign effectiveness, and customer engagement.
  • Support field teams by ensuring digital strategies integrate seamlessly with CRM workflows and sales execution.
  • Manage vendor relationships and budgets related to digital platforms, AI tools, and marketing technology solutions.

Desired Qualifications

  • An MBA or advanced degree is preferred.
  • Experience supporting pharmaceutical product launches or pre-launch commercial environments is strongly preferred.

About the Company

Compass Pathways

Develops psilocybin-based therapies for TRD

COMPASS Pathways develops psilocybin-based therapies for mental health, focusing on treating treatment-resistant depression (TRD). Its lead drug candidate, COMP360, is a high-purity psilocybin formulation given alongside psychological support from trained therapists. The treatment is delivered through a global Phase 3 program, aiming to establish a regulatory-approved therapy. Compared with other players, COMPASS emphasizes a standardized therapeutic model that pairs a pharmaceutical compound with guided psychotherapy and has the largest psilocybin Phase 3 program to date, supported by Breakthrough Therapy designation from the FDA. The company originated from a nonprofit idea, transformed into a for-profit entity to fund extensive trials, and is pursuing regulatory approval and eventual commercialization through licensing and partnerships. Its goal is to bring approved, evidence-based psilocybin treatments to patients with TRD and scale access through a commercial pathway.

Company size
201-500
Company stage
IPO
Headquarters
London, United Kingdom
Founded
2016

Recently Posted Jobs

Explore more opportunities at Compass Pathways

See more jobs